A Biological Framework for Multiple Sclerosis
MS can be considered a spectrum, researchers proposed
Stay updated with breaking news from Bruce Cree. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MS can be considered a spectrum, researchers proposed
Sustained efficacy was confirmed with an annualized relapse rate of 0.098 and 67% of patients were relapse-free at six years Safety was consistent with prior findings and the established safety...
Bristol Myers Squibb today announced new results from a Phase 3 trial, demonstrating the long-term efficacy and safety profile of Zeposia in patients with relapsing forms of multiple sclerosis . In...
A study will seek to answer whether CAR T-cell therapy using KYV-101 offers a new treatment option for patients living with MS.
"Serious infections did not vary by age, and there were too few serious events to identify any age-related trends by specific TEAE," the authors reported.